Literature DB >> 6185428

Antigenic determinant of the Lancefield group H antigen of Streptococcus sanguis.

B Rosan, L Argenbright.   

Abstract

Previous studies indicated that the teichoic acid isolated from strains of Streptococcus sanguis was group specific and defined the Lancefield group H streptococci. To determine the specific antigenic determinants, the antigen was extracted from a group H streptococcus (ATCC 903) by the phenol-water method and purified by column chromatography. The isolated antigen had a glycerol/phosphate/glucose molar ratio of 1:0.9:0.3; the lipid concentration was 7.6% of its dry weight. No nucleic acids were detected, and amino acids constituted approximately 2% of the dry weight. The minimum concentration of antigen required to sensitize erythrocytes for hemagglutination with a 1:1,000 dilution of either group H antiserum or antiteichoic acid serum was 0.02 microgram/ml. Hemagglutination inhibition studies suggested that the major antigenic determinant consisted of an alpha-glucose linked to the glycerol phosphate backbone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185428      PMCID: PMC347838          DOI: 10.1128/iai.38.3.925-931.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Use of autoclaved extracts of hemolytic streptococci for serological grouping.

Authors:  L A RANTZ; E RANDALL
Journal:  Stanford Med Bull       Date:  1955-05

2.  Serological subdivisions among the Lancefield group H streptococci.

Authors:  E D FARMER
Journal:  J Gen Microbiol       Date:  1954-10

3.  Streptococcus S.B.E.: Immunological Characteristics.

Authors:  M R Washburn; J C White; C F Niven
Journal:  J Bacteriol       Date:  1946-06       Impact factor: 3.490

4.  Streptococcus S.B.E.: A Streptococcus Associated with Subacute Bacterial Endocarditis.

Authors:  J C White; C F Niven
Journal:  J Bacteriol       Date:  1946-06       Impact factor: 3.490

5.  Studies on the group F antigen of lactobacilli: detection of antibodies by haemagglutination.

Authors:  M J Hewett; K W Knox; A J Wicken
Journal:  J Gen Microbiol       Date:  1970-03

6.  Studies on the group F antigen of lactobacilli: isolation of a teichoic acid-lipid complex from Lactobacillus fermenti NCTC 6991.

Authors:  A J Wicken; K W Knox
Journal:  J Gen Microbiol       Date:  1970-03

7.  Antigens of Streptococcus sanguis: purification and characterization of the b antigen.

Authors:  B Appelbaum; B Rosan
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  Relationship of the cell wall composition of group H streptococci and Streptococcus sanguis to their serological properties.

Authors:  B Rosan
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

9.  Antigens of Streptococcus sanguis.

Authors:  B Rosan
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

10.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

View more
  3 in total

1.  Insertional inactivation of genes responsible for the D-alanylation of lipoteichoic acid in Streptococcus gordonii DL1 (Challis) affects intrageneric coaggregations.

Authors:  D L Clemans; P E Kolenbrander; D V Debabov; Q Zhang; R D Lunsford; H Sakone; C J Whittaker; M P Heaton; F C Neuhaus
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Structural and antigenic types of cell wall polysaccharides from viridans group streptococci with receptors for oral actinomyces and streptococcal lectins.

Authors:  J O Cisar; A L Sandberg; G P Reddy; C Abeygunawardana; C A Bush
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

3.  Surface structures (peritrichous fibrils and tufts of fibrils) found on Streptococcus sanguis strains may be related to their ability to coaggregate with other oral genera.

Authors:  P S Handley; P L Carter; J E Wyatt; L M Hesketh
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.